ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2412

Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records

Neera Narang1 and Eswar Krishnan2, 1Stanford Univ Medical Center, Stanford, CA, 2Medicine, Standford University, Palo Alto, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Diagnosis and gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Electronic Medical Records (EMR) offer great opportunities for pharmacoepidemiologic, health outcome and health services research. However, the critical limiting factor in the widespread use of these data is the accuracy, precision and validity of diagnoses.  EpicCare is a large and growing proprietary EMR software system that has been adopted by several large tertiary care facilities.The goal of this FDA funded project was to assess the validity of an ICD code of 274.* to identify patients meeting a clinical diagnosis of gout from among those who have ever been prescribed colchicine.

Methods: We identified 143 patients in the Stanford EpicCare system in the past 6 years that met our case definition for gout -at least one prescription of colchicine and one instance of ICD-9 code of 274.*. The records of these patients were individually reviewed and data on the following aspects were abstracted: physician diagnosis (notes), performance of arthrocentesis, use of urate lowering therapy, and documentation of each of the American College of Rheumatology (ACR) criteria for diagnosis/classification of gout. Data were analyzed quantitatively and qualitatively.

Results: Overall 143 case records were reviewed, of which 3 did not have any physician authored clinical documents. A physician diagnosis of gout was documented in 114 (80%). Three charts revealed a diagnosis of pseudogout and 31 did not have any physician documentation of gout. Among those records with a physician diagnosis of gout, 35 records documented intra-articular urate  crystals, 36 records had documentation that met the ACR criteria, and 19 records had documentation of ACR criteria and urate crystals. The median number of ACR criteria met in the 114 charts was 4, with an interquartile range of 2 to 6. Among those records with a positive crystal identification, only 48% had documentation that met the ACR criteria. Among those records where arthrocentesis was performed and found to be negative for crystals, physician diagnosis was documented in 90%, and ACR criteria were met in 40%.  In the case records that did not show documentation of arthrocentesis or any relevant laboratory evaluation, 75% had physician diagnosis and about 13% met the American College of Rheumatology criteria.

Conclusion: This study showed that in the setting of a tertiary medical center, Electronic Medical Records are an excellent resource for gout research.  Documentation of the individual ACR criteria and performance of arthrocentesis is infrequent and hence these may not be useful gold standards for validation studies of gout in the EMR. From our qualitative review, documentation of physician diagnosis may be considered a useful benchmark for assessing the utility of case definitions for gout.


Disclosure:

N. Narang,
None;

E. Krishnan,

savient,

1,

URL, takeda, metbolex,ARDEA,

2,

METABOLEX TAKEDA,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/valdiation-of-a-diagnosis-of-gout-in-the-epiccare-electronic-medical-records/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology